ProShares UltraShort NASDAQ Biotechnology
8 hedge funds and large institutions have $984K invested in ProShares UltraShort NASDAQ Biotechnology in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and closing their positions.
Holders
8
Holders Change
+1
Holders Change %
+14.29%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
4
Closed
–
Calls
$8K
Puts
$10K
Net Calls
-$2K
Net Calls Change
-$29K
Top Buyers
| 1 |
TRCT
1
Tower Research Capital (TRC)
New York
|
$173K |
| 2 |
2
Simplex Trading
Chicago,
Illinois
|
$6K |
Top Sellers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$22.7K |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$424K |
| 3 |
3
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$354K |
| 4 |
4
Morgan Stanley
New York
|
$2.52K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Citadel Advisors
Miami,
Florida
| $424K | 20,321 | -2,261 | -10% |
|
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $354K | 16,993 | -1,104 | -6% |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| $173K | 8,279 | +6,648 | +408% |
|
|
4
UBS Group
Zurich,
Switzerland
| $22.7K | 1,089 | -2,535 | -70% |
|
|
5
Simplex Trading
Chicago,
Illinois
| $6K | 328 | +328 | New |
|
|
6
Morgan Stanley
New York
| $2.52K | 121 | -30 | -20% |
|
7
Citigroup
New York
| $1.77K | 85 | – | – |
|
8
Osaic Holdings
Scottsdale,
Arizona
| $1.04K | 50 | – | – |
|
|
CFGS
9
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|